81 related articles for article (PubMed ID: 9470833)
41. High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy.
Jackson GH; Angus B; Carey PJ; Finney RD; Galloway MJ; Goff DK; Haynes A; Lennard AL; Leonard RC; McQuaker IG; Proctor SJ; Russell N; Windebank K; Taylor PR;
Leuk Lymphoma; 2000 May; 37(5-6):561-70. PubMed ID: 11042516
[TBL] [Abstract][Full Text] [Related]
42. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
Lu YS; Hsu C; Li CC; Kuo SH; Yeh KH; Yang CH; Hsu CH; Wu CY; Cheng AL
Hepatogastroenterology; 2004; 51(57):815-9. PubMed ID: 15143923
[TBL] [Abstract][Full Text] [Related]
43. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
[TBL] [Abstract][Full Text] [Related]
44. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.
Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH
Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408
[TBL] [Abstract][Full Text] [Related]
45. [Dose-response effect of drugs in the chemotherapy of small-cell bronchial carcinoma].
Kostić D; Jelić S; Radulović S
Srp Arh Celok Lek; 2000; 128(3-4):75-9. PubMed ID: 10932613
[TBL] [Abstract][Full Text] [Related]
46. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
47. Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
Ferrari D; Di Maria G; Fazio N; Codecà C; Fiore J; Luciani A; Oldani S; Maggioni M; Foa P
Anticancer Drugs; 2008 Sep; 19(8):837-40. PubMed ID: 18690097
[TBL] [Abstract][Full Text] [Related]
48. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
[TBL] [Abstract][Full Text] [Related]
49. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
[TBL] [Abstract][Full Text] [Related]
50. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
51. Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics.
Paccagnella A; Favaretto A; Riccardi A; Danova M; Ghiotto C; Giordano M; Pappagallo G; Comis S; Panozzo M; Chieco-Bianchi L
Cancer; 1993 Aug; 72(3):697-706. PubMed ID: 8392903
[TBL] [Abstract][Full Text] [Related]
52. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
53. Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
Barone C; Corsi DC; Pozzo C; Cassano A; Fontana T; Noviello MR; Landriscina M; Colloca G; Astone A
Cancer; 1998 Apr; 82(8):1460-7. PubMed ID: 9554521
[TBL] [Abstract][Full Text] [Related]
54. A phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinoma.
Raderer M; Pidlich J; Müller C; Pfeffel F; Kornek GV; Hejna M; Scheithauer W
Eur J Cancer; 1996 Dec; 32A(13):2366-8. PubMed ID: 9038625
[No Abstract] [Full Text] [Related]
55. A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinoma.
Miller KD; Loehrer PJ; Gonin R; Weber G; Ansari R; Pletcher W; McClean J; Spiridonidis CH; Mortimer J
Invest New Drugs; 1996; 14(2):207-12. PubMed ID: 8913842
[TBL] [Abstract][Full Text] [Related]
56. Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC).
Wierzbicki R; Ezzat A; Abdel-Warith A; Ayoub A; Kagevi I; Fadda M; Sieck J; Abdulkareem M; Amin T; Yazigi A
Ann Oncol; 1994 May; 5(5):466-7. PubMed ID: 8075054
[No Abstract] [Full Text] [Related]
57. Primary liver cancer in Hong Kong.
Shiu WC
Cancer Chemother Pharmacol; 1992; 31 Suppl():S143-5. PubMed ID: 1458565
[TBL] [Abstract][Full Text] [Related]
58. Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment.
Wu R; Li XY; Wang WH; Cai FF; Chen XL; Yang MD; Pan QS; Chen QL; Zhou RY; Su SB
Evid Based Complement Alternat Med; 2019; 2019():3242989. PubMed ID: 31015849
[TBL] [Abstract][Full Text] [Related]
59. Hepatocellular Carcinoma in an HIV Patient "Cured" of Hepatitis C Virus.
Swaminath A
Gastroenterol Hepatol (N Y); 2006 Aug; 2(8):599-602. PubMed ID: 28316530
[No Abstract] [Full Text] [Related]
60. Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology.
Gao L; Wang XD; Niu YY; Duan DD; Yang X; Hao J; Zhu CH; Chen D; Wang KX; Qin XM; Wu XZ
Sci Rep; 2016 May; 6():24944. PubMed ID: 27143508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
